A survey of Australian and New Zealand old age psychiatrists' preferred medications to treat behavioral and psychological symptoms of dementia (BPSD)

International Psychogeriatrics

Volumn 17, Issue 2, 2005, Pages 195-205

  Greve, Melissa ^a   O'Connor, Daniel ^b,c  

^a Broadmeadows Health Service   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Kingston Centre   (Australia)

Author keywords

Aged psychiatry; Behavior; Dementia; Medication

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; DIAZEPAM; HALOPERIDOL; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OXAZEPAM; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE; THIORIDAZINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

AGGRESSION; AUSTRALIA; BEHAVIOR DISORDER; CLINICAL TRIAL; DEMENTIA; DISEASE ASSOCIATION; DRUG POTENCY; GAIT DISORDER; HUMAN; MEDICAL PRACTICE; NEW ZEALAND; PRESCRIPTION; PSYCHIATRIST; PSYCHOSIS; REVIEW; SOMNOLENCE; TREATMENT INDICATION;

AGED; ANTIPSYCHOTIC AGENTS; AUSTRALIA; DEMENTIA; HUMANS; NEW ZEALAND; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRY; SOCIAL BEHAVIOR DISORDERS;

EID: 23044438354     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610205001481     Document Type: Review

References (19)

1. Alexopoulos, G. S., Silver, J. M., Kahn, D. A., Frances, A. and Carpenter, D. (1998). Treatment of agitation in older persons with dementia. Postgraduate Medicine Special Report, April, 1-88.
2. Brook, R. H. et al. (1986). A method for the detailed assessment of the appropriateness of medical technologies. International Journal of Technology Assessment in Health Care, 2, 53-63.
3. Burgio, L. D. et al. (1992). A behavioural microanalysis of the effects of haloperidol and oxazepam in demented psychogeriatric inpatients. International Journal of Geriatric Psychiatry, 7, 253-262.
4. Committee on Safety of Medicines. (2004). Atypical antipsychotic drugs and stroke. Available at: http://medicines.mhra.gov.uk/ourwork/ monitorsafequalmed/messages/risperidone-clinicaltrialdatafinal.pdf. Date of Access: May 13, 2004.
5. Condren, R. M. and Cooney, C. (2001). Use of drugs by Old Age Psychiatrists in the treatment of psychotic and behavioral symptoms in patients with dementia. Aging and Mental Health, 5, 235-241.
6. De Deyn, P. P. et al. (1999). A randomized trial of risperidone, placebo and haloperidol for behavioural symptoms of dementia. Neurology, 53, 946-955.
7. Draper, B. et al. (2001). Use of psychotropics in Sydney nursing homes: associations with depression, psychosis and behavioral disturbances. International Psychogeriatrics, 13, 107-120.
8. International Psychogeriatric Association (IPA) (2002). Behavioral and Psychological Symptoms of Dementia (BPSD) Educational Pack: Module 6. Chicago: IPA.
9. Katz, I. R. et al. (1999). Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia: a randomised, double-blind trial. Journal of Clinical Psychiatry, 60, 107-115.
10. O'Connor, D. W. (2000). Epidemiology of behavioral and psychological symptoms of dementia. International Psychogeriatrics, 12 (Suppl. 1), 41-45.
11. O'Connor, D. W., Pollitt, P. A., Roth, M., Brook, C. P. B. and Reiss, B. B. (1990). Problems reported by relatives in a community study of dementia. British Journal of Psychiatry, 156, 835-841.
12. O'Connor, D. W., Pollitt, P. A., Brook, C. P. B, Reiss, B. B. and Roth, M. (1991). Does early intervention reduce the number of elderly people with dementia admitted to institutions for long term care? British Medical Journal, 302, 871-875.
13. Opie, J., Rosewarne, R. and O'Connor, D. W. (1999). The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review. Australian and New Zealand Journal of Psychiatry, 33, 789-799.
14. Opie, J., Doyle, C. and O'Connor, D. W. (2002). Challenging behaviours in nursing home residents with dementia: a randomised controlled trial of multi-disciplinary interventions. International Journal of Geriatric Psychiatry, 17, 6-13.
15. Schneider, L. S. (1996). Meta-analysis of controlled pharmacologic trials. International Psychogeriatrics, 8 (Suppl. 3), 375-379.
16. Scottish Intercollegiate Guidelines Network. (1998). Interventions in the Management of Behavioural and Psychological Aspects of Dementia. Edinburgh: SIGN.
17. Street, J. S. et al. (2000). Olanzapine treatment of psychotic and behavioural symptoms in patients with Alzheimer's disease in nursing care facilities. Archives of General Psychiatry, 57, 968-976.
18. Sultzer, D. L., Gray, K. F., Gunay, I., Berisford, M. A. and Mahler, M. E. (1997). A double-blind comparison of trazadone and haloperidol for treatment of agitation in patients with dementia. American Journal of Geriatric Psychiatry, 5, 60-69.
19. Teri, L. et al. (2000). Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology, 55, 1271-1278.